Ketamines for Treatment Resistant Depression in Patients with Chronic Pain and Opioid Use
Michael Hart, Zack Z. Cernovsky
Archives of Psychiatry and Behavioral Sciences 2019 DOI: 10.22259/2638-5201.0202008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Population | Patients with history of chronic pain and treatment-resistant major depression |
| Intervention | Ketamine |
| Topics | Depression Esketamine Ketamine |
| Keywords | Depression economics Chronic pain Opioid Receptor |
| Citations | 1 |
| Key points | Ketamine may be effective for treating major depression in patients with a history of chronic pain who have not responded to standard antidepressants. |
Abstract
present study extends the application of ketamine to patients with history of not only chronic
Citations in the library
Cites 3
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study American Journal of Psychiatry May 21, 2019
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression JAMA Psychiatry December 27, 2017
- Ketamine for Depression, 3: Does Chirality Matter? The Journal of Clinical Psychiatry June 27, 2017